This article explains, in educational terms, balloon angioplasty (pta) — how the technology works and where it fits. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Peripheral Arterial Disease (PAD)
Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing. Endovascular therapy aims to restore flow through the narrowed segment using balloons, stents, atherectomy, or a combination. Peripheral arterial disease is the narrowing of arteries outside the heart — most often in the legs — due to atherosclerotic plaque, reducing blood flow to the limbs.
Balloon Angioplasty (PTA)
Percutaneous transluminal angioplasty inflates a balloon within the narrowed artery to compress plaque and widen the lumen, restoring flow. It is a foundational PAD technique, often used alone or as preparation before stenting. Balloon diameter and length are matched to the vessel to avoid over- or under-dilation. INVAMED's PTA balloon range is designed to cover common peripheral vessel sizes.
Design and Technical Notes
INVAMED's PAD portfolio spans access, plaque modification, angioplasty, drug delivery, stenting, and embolic protection. INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals. Access sheath sizing should match the planned devices to limit access-site complications.
Key Considerations
- Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting.
- Access sheath sizing should match the planned devices to limit access-site complications.
- Manufacturer figures reflect studied device performance, not guaranteed outcomes.
Frequently Asked Questions
Why use embolic protection?
It captures plaque or clot fragments dislodged during treatment so they do not travel downstream; it is often paired with atherectomy.
Are these devices CE marked?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Who decides which PAD device to use?
A vascular specialist selects devices based on lesion characteristics; this content is educational and not a treatment recommendation.
Clinical and Technical Context
Endovascular therapy aims to restore flow through the narrowed segment using balloons, stents, atherectomy, or a combination. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist. Balloon diameter and length are matched to the vessel to avoid over- or under-dilation. INVAMED's Invaducer introducer sheath sets support the access step of peripheral interventions. Symptoms range from exertional leg pain (claudication) to, in severe cases, rest pain and non-healing wounds known as critical limb ischemia. Manufacturer figures reflect studied device performance, not guaranteed outcomes. Appropriate access selection helps reduce access-site complications. INVAMED's TemREN atherectomy system is positioned for peripheral plaque modification. INVAMED's Atlas peripheral stent graft addresses covered-stent applications in the PAD portfolio. INVAMED's PTA balloon range is designed to cover common peripheral vessel sizes. INVAMED's Guardian protection device is designed for this distal-capture role. Covered stent grafts can be used to exclude certain lesions or manage complications. INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals. Drug dose and balloon sizing follow the device specifications and lesion characteristics. Access sheath sizing should match the planned devices to limit access-site complications. Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion.
Related on INVAMED
- Peripheral Arterial Disease (PAD) — product category
- Peripheral Stenting Explained — A Technical Guide
- Atlas Endovascular Peripheral Stent Graft: Features, Specifications and Clinical Role
- What is recovery time after leg angioplasty?
Important Disclaimer
The information here is provided for educational purposes and to describe device technology; it is not a substitute for professional medical advice, diagnosis, or treatment. Only a licensed healthcare provider can determine whether a given procedure or device is appropriate for a specific patient. INVAMED products are restricted to use by qualified professionals following the official IFU. Regulatory clearance and labeling differ between regions, and not all products or indications are available in every market.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.